The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-L1 status and efficacy of immune check-point inhibitors (ICIs) in advanced cancer patients: a pooled analysis of randomized trials.
 
Federica Biello
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Boehringer Ingelheim; Roche
 
David James Pinato
Consulting or Advisory Role - Eisai; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb
 
Gloria Borra
Honoraria - Bristol-Myers Squibb; MSD; Roche
 
Silvia Genestroni
Speakers' Bureau - Roche
 
Guido Siffredi
No Relationships to Disclose
 
Ilaria Repetti
No Relationships to Disclose
 
Veronica Martini
No Relationships to Disclose
 
Feba mariam Varughese
No Relationships to Disclose
 
Ajay Ram Vachanaram
No Relationships to Disclose
 
Edoardo Mora
No Relationships to Disclose
 
Simone Nardin
No Relationships to Disclose
 
Paolo Bruzzi
Honoraria - Celgene; Merk Sharp & Dome; Novartis; Takeda
Consulting or Advisory Role - AstraZeneca; Eisai
Speakers' Bureau - Lilly; Pfizer
 
Antonio Sica
No Relationships to Disclose
 
Alessandra Gennari
Honoraria - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; MSD; Novartis; Pfizer; Roche; Teva
Research Funding - Eisai